Bovilis Ringvac is an injectable live vaccine to reduce clinical signs, aid recovery and help prevent ringworm in cattle.
Lyophilisate for suspension for injection with solvent for reconstitution
Per ml after reconstitution:
7 x 106 and ≤ 21 x 106 viable microconidia of Trichophyton verrucosum strain LTF-130
Indications for use
For active immunisation of cattle to reduce clinical signs of ringworm caused by Trichophyton verrucosum (prophylactic dose) and to shorten the recovery time of infected cattle showing clinical signs of ringworm (therapeutic dose).
Cattle already infected with, or in the incubation of infection with Trichophyton verrucosum, should not be vaccinated with the prophylactic dose. In such cases, animals show signs of the disease which could be severe. These animals should be given the therapeutic dose.
Cattle - milk 0 hours, meat 0 days
Cardboard box with 1 x 5 calf doses and 1 x 10 ml solvent in glass bottles closed with a rubber stopper/aluminium combination cap.
Cardboard box with 1 x 20 calf doses and 1 x 40 ml solvent in glass bottles closed with a rubber stopper/aluminium combination cap.
For both presentations the vaccine is contained into 10 ml glass vials of Ph. Eur. Type I quality, while the solvent is contained into 10 ml (5-dose presentation) or 50 ml (20-dose presentation) glass vials of Ph. Eur. Type II quality. Both the vaccine and the solvent vials are closed with bromobutyl rubber stoppers of Ph. Eur. Type I quality. Not all presentations may be marketed.
For full information please refer to the product data sheet. Further information is available on request.
Use Medicines Responsibly. For more information please refer to the Responsible Use sections of the NOAH website.
If you are not the prescribing veterinary surgeon, advice should be sought from the medicine prescriber.
Date of preparation: January 2018